Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 901–1,000 of 1,009
Zhang, Q., Wan, R., & Liu, C. (2020) · Medicine · doi:10.1097/md.0000000000021677 · Cited by 44
Kakehashi, A., Suzuki, S., Ishii, N., Okuno, T., Kuwae, Y., Fujioka, M., Gi, M., Стефанов, В. Е., & Wanibuchi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207746 · Cited by 38
Sheng, L., Jena, P. K., Hu, Y. C., & Wan, Y. Y. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-671 · Cited by 39
The role of gut microbiota in tumorigenesis and treatment
Xu, J., Liu, M.-T., Tao, T., Zhu, X. M., & Fei, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111444 · Cited by 45
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Michelotti, A., de Scordilli, M., Palmero, L., Guardascione, M., Masala, M., Roncato, R., Foltran, L., Ongaro, E., & Puglisi, F. (2021) · Cells · doi:10.3390/cells10082034 · Cited by 48
Nutrition and cellular senescence in obesity-related disorders
Rubio‐Tomás, T., Rueda‐Robles, A., Plaza‐Díaz, J., & Álvarez‐Mercado, A. I. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108861 · Cited by 43
The altered lipidome of hepatocellular carcinoma
Tan, S. L. W., Israeli, E., Ericksen, R. E., Chow, P. K. H., & Han, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.004 · Cited by 39
Igarashi, N., Miyata, K., Loo, T. M., Chiba, M., Hanyu, A., Nishio, M., Kawasaki, H., Zheng, H., Toyokuni, S., Kon, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31642-4 · Cited by 38
Self-citationMorchella esculenta polysaccharide attenuate obesity, inflammation and modulate gut microbiota
Rehman, A. U., Khan, A. I., Xin, Y., & Liang, W. (2022) · AMB Express · doi:10.1186/s13568-022-01451-5 · Cited by 38
Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2015) · Scientific Reports · doi:10.1038/srep17528 · Cited by 39
Diet-microbiome interactions in cancer
Abdeen, S. K., Mastandrea, I., Stinchcombe, N., Puschhof, J., & Elinav, E. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.013 · Cited by 36
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 39
CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
Li, K., Zhang, J., Lyu, H., Yang, J., Wei, W., Wang, Y., Luo, H., Zhang, Y., Jiang, X. J., Yi, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202306827 · Cited by 47
Jeong, S., Oh, Y. H., Ahn, J. C., Choi, S., Park, S. J., Kim, H. J., Lee, G., Son, J. S., Jang, H., Lee, D. H., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0145 · Cited by 43
Li, S., Ma, W., FEI, T., Lou, Q., Zhang, Y., Cui, X., QIN, X., Zhang, J., Liu, G., Dong, Z. F., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2547 · Cited by 37
Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
Riordan, J. D., & Nadeau, J. H. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9521-3 · Cited by 40
The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases
Neves, A. L., Chilloux, J., Sarafian, M. H., Rahim, M. B. A., Boulangé, C. L., & Dumas, M.-E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.013 · Cited by 36
Dietary sugar intake increases liver tumor incidence in female mice
Healy, M. E., Lahiri, S., Hargett, S. R., Chow, J. D. Y., Byrne, F. L., Breen, D. S., Kenwood, B. M., Taddeo, E. P., Lackner, C., Caldwell, S. H., et al. (2016) · Scientific Reports · doi:10.1038/srep22292 · Cited by 36
Kimura, T., Kobayashi, A., Tanaka, N., Sano, K., Komatsu, M., Fujimori, N., Yamazaki, T., Shibata, S., Ichikawa, Y., Joshita, S., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12762 · Cited by 36
Ozawa, T., Maehara, N., Kai, T., Arai, S., & Miyazaki, T. (2016) · Genes to Cells · doi:10.1111/gtc.12446 · Cited by 45
Gut-liver axis: gut microbiota in shaping hepatic innate immunity
Wu, X., & Tian, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9128-3 · Cited by 37
Ma, Q., Huang, D.-Y., Zhang, H., Wang, S., & Chen, X.-F. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.024 · Cited by 38
Xiong, F., Wu, S., Lu, Q., Shi, M., Li, W., Zou, H., Li, M., & Wang, G. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.10.015 · Cited by 36
The aged liver: Beyond cellular senescence
Allaire, M., & Gilgenkrantz, H. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.07.011 · Cited by 41
Repeated mild traumatic brain injury affects microbial diversity in rat jejunum
Matharu, D., Dhotre, D. P., Balasubramanian, N., Pawar, N., Sagarkar, S., & Sakharkar, A. J. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9940-0 · Cited by 39
Sun, L. M., Bao, L., Phurbu, D., Qiao, S., Sun, S., Perma, Y., & Liu, H. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.04.006 · Cited by 39
Singh, D., Khan, M. A., & Siddique, H. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120008 · Cited by 38
Hou, J.-J., Wang, X., Wang, Y.-M., & Wang, B.-M. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2018401 · Cited by 38
Yan, H., Chen, Y., Zhu, H., Huang, W., Cai, X.-H., Li, D., Lv, Y.-J., Si-Zhao, Zhou, H., Luo, F., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.829304 · Cited by 40
Diwan, B., & Sharma, R. (2022) · Food Science and Biotechnology · doi:10.1007/s10068-022-01114-y · Cited by 40
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
van Best, N., Jansen, P. L. M., & Rensen, S. S. (2015) · Hepatology International · doi:10.1007/s12072-015-9640-2 · Cited by 38
Li, D., Zhou, J., Wang, L., Gong, Z., Le, H., Huang, Y., Xu, C., Tian, C., Cai, W., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01109-0 · Cited by 35
“Increasing evidence indicates that the alteration of gut microbiota and consequently elevating of microbial metabolites deoxycholic acid (DCA) induced by HFD play significant roles in inducing intestinal inflammation and colorectal malignancies [8–11].”
BackgroundZhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01604-7 · Cited by 35
“It has been confirmed that high-mobility group box 1protein (HMGA1) is involved in the regulation of the secretion of pro-inflammatory SASPs (IL-6, IL-8, etc.) through the regulation of NAMPT and ultimately the NAD/NADH ratio [43], and that pro-inflammatory SASP has a pro-tumorigenic effect [44].”
BackgroundThe Aged Intestine: Performance and Rejuvenation
Wang, Q., Qi, Y., Shen, W., Xu, J., Wang, L., Chen, S., Hou, T., & Si, J. (2021) · Aging and Disease · doi:10.14336/ad.2021.0202 · Cited by 40
Takada, N., Takasugi, M., Nonaka, Y., Kamiya, T., Takemura, K., Satoh, J., Ito, S., Fujimoto, K., Uematsu, S., Yoshida, K., et al. (2022) · Development · doi:10.1242/dev.199443 · Cited by 37
Self-citationBai, Z., Liu, Y., Zhao, Y., Yan, R., Yang, L., Ma, H., Wang, J., Wang, T., Li, Y., Zhang, G., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110296 · Cited by 37
Effenberger, M., Waschina, S., Bronowski, C., Sturm, G., Tassiello, O., Sommer, F., Zollner, A., Watschinger, C., Grabherr, F., Gstir, R., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000182 · Cited by 40
Impacts of gut microbiota alteration on age-related chronic liver diseases
Adhikary, S., Esmeeta, A., Dey, A., Banerjee, A., Saha, B., Gopan, P., Duttaroy, A. K., & Pathak, S. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.017 · Cited by 38
Zhou, Y., Zhang, L., Ma, Y., Xie, L. H., Yang, Y.-Y., Cheng, J., Chen, H., Zhou, Y., Song, G., Ding, J., et al. (2023) · Theranostics · doi:10.7150/thno.85369 · Cited by 38
Benbow, J. H., Thompson, K. J., Cope, H. L., Brandon-Warner, E., Culberson, C. R., Bossi, K. L., Li, T., Russo, M. W., Gersin, K. S., McKillop, I. H., et al. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.09.015 · Cited by 35
Strategies to increase the efficacy of using gut microbiota for the modulation of obesity
Li, J., Rajoka, M. S. R., Shao, D., Jiang, C., Jin, M., Huang, Q., Yang, H., & Shi, J. (2017) · Obesity Reviews · doi:10.1111/obr.12590 · Cited by 40
Sphingolipids at the Crossroads of NAFLD and Senescence
Nikolova‐Karakashian, M. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.05.002 · Cited by 41
Outside the liver box: The gut microbiota as pivotal modulator of liver diseases
Wahlstrom, A. M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.004 · Cited by 37
Secondary Unconjugated Bile Acids Induce Hepatic Stellate Cell Activation
Saga, K., Iwashita, Y., Hidano, S., Aso, Y., Isaka, K., Kido, Y., Tada, K., Takayama, H., Masuda, T., Hirashita, T., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103043 · Cited by 38
Novel cancer therapy targeting microbiome
Nagano, T., Otoshi, T., Hazama, D., Kiriu, T., Umezawa, K., Katsurada, N., & Nishimura, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207546 · Cited by 39
The impact of metabolites derived from the gut microbiota on immune regulation and diseases
Ohno, H. (2020) · International Immunology · doi:10.1093/intimm/dxaa041 · Cited by 38
Understanding the effects of dietary components on the gut microbiome and human health
Rackerby, B., Kim, H. J., Dallas, D. C., & Park, S. H. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-020-00811-w · Cited by 43
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
Muhammed, A., D’Alessio, A., Enica, A., Talbot, T., Fulgenzi, C. A. M., Nteliopoulos, G., Goldin, R. D., Cortellini, A., & Pinato, D. J. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2049244 · Cited by 38
Konishi, Y., Okumura, S., Matsumoto, T., Itatani, Y., Nishiyama, T., Okazaki, Y., Shibutani, M., Ohtani, N., Nagahara, H., Obama, K., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4671 · Cited by 37
Self-citationMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 41
Wang, N., Yang, J., Han, W., Han, M., Liu, X., Jiang, L., Cao, H., Jing, M., Sun, T., & Xu, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1029905 · Cited by 39
Hutcheson, J., Bourgo, R. J., Balaji, U., Ertel, A., Witkiewicz, A. K., & Knudsen, E. S. (2014) · Hepatology · doi:10.1002/hep.27217 · Cited by 38
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification
Panasevich, M. R., Peppler, W. T., Oerther, D. B., Wright, D. C., & Rector, R. S. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00012.2017 · Cited by 37
Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
Sharpton, S. R., Yong, G. J. M., Terrault, N. A., & Lynch, S. V. (2018) · Hepatology Communications · doi:10.1002/hep4.1284 · Cited by 39
IL-22 Signaling in the Tumor Microenvironment
Jiang, R., & Sun, B. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-55617-4_5 · Cited by 35
MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options
Leyh, C., Coombes, J. D., Schmidt, H., Canbay, A. E., Manka, P. P., & Best, J. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040370 · Cited by 44
Yang, L., Qiu, J., Xiao, Y., Hu, X., Liu, Q., Chen, L., Huang, W., Li, X., Li, L., Zhang, J., et al. (2018) · Theranostics · doi:10.7150/thno.25166 · Cited by 35
Insights Into the Origin of Intrahepatic Cholangiocarcinoma From Mouse Models
Zhu, Y. Y., & Kwong, L. N. (2020) · Hepatology · doi:10.1002/hep.31200 · Cited by 39
Effects of Microbiota on the Treatment of Obesity with the Natural Product Celastrol in Rats
Hu, W., Wang, L., Du, G., Guan, Q., Dong, T., Song, L., Xia, Y., & Wang, X. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0124 · Cited by 37
Conceptualizing the Vertebrate Sterolbiome
Ridlon, J. M. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.00641-20 · Cited by 37
Gut microbiota mediated molecular events and therapy in liver diseases
Qi, X., Yang, M. J., Stenberg, J., Dey, R., Fogwe, L., Alam, M. S., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i48.7603 · Cited by 34
Diet and gut microbiome in fatty liver and its associated liver cancer
Pan, Y., & Zhang, X. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15713 · Cited by 40
Mycotoxins and cellular senescence: the impact of oxidative stress, hypoxia, and immunosuppression
Li, Y., Nepovimová, E., Valko, M., Wu, Q., & Kuča, K. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03423-x · Cited by 39
Microbiome and Metabolomics in Liver Cancer: Scientific Technology
Ganesan, R., Yoon, S. J., & Suk, K. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010537 · Cited by 37
Analysis of Clostridium cluster XI bacteria in human feces
OHASHI, Y., & Fujisawa, T. (2018) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-023 · Cited by 42
Western diet influences on microbiome and carcinogenesis
Newsome, R. C., Yang, Y., & Jobin, C. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101756 · Cited by 37
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
Cocomazzi, G., Pup, L. D., Contu, V., Maggio, G., Parmegiani, L., Ciampaglia, W., Ruvo, D. D., Faioli, R., Maglione, A., Baldini, G. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042237 · Cited by 35
The enteric microbiome in hepatobiliary health and disease
Tabibian, J. H., Varghese, C., LaRusso, N. F., & O’Hara, S. P. (2015) · Liver International · doi:10.1111/liv.13009 · Cited by 36
González-Ferrero, C., Irache, J. M., Marín-Calvo, B., Ortiz-Romero, L., Virto, R., & González-Navarro, C. J. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1724203 · Cited by 33
The Microbiome and Hepatocellular Carcinoma
Rattan, P., Minacapelli, C. D., & Rustgi, V. K. (2020) · Liver Transplantation · doi:10.1002/lt.25828 · Cited by 34
Wang, R., Fan, X., Lu, Y., Chen, D., Zhao, Y., & Qi, K. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.10.021 · Cited by 39
Shimizu, R., Kanno, K., Sugiyama, A., Ohata, H., Araki, A., Kishikawa, N., Kimura, Y., Yamamoto, H., Kodama, M., Kihira, K., et al. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.256 · Cited by 33
Implication of Gut Microbiota in Human Health
Khan, I., Yasir, M., Azhar, E. I., Kumosani, T. A., Barbour, E. K., Bibi, F., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023153506 · Cited by 43
Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma
Rajesh, Y., & Sarkar, D. (2020) · Cancers · doi:10.3390/cancers12051290 · Cited by 35
Commentary: Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Jia, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00282 · Cited by 35
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Wu, Q., Yang, Y., Lin, S., Geller, D. A., & Yan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1569915 · Cited by 32
“Notably, interventions such as antibiotic administration and intestinal sterilization have been shown to decrease the incidence of HCC in obese mice, underscoring the signi fi cant role of microbiota dysbiosis in the pathogenesis of HCC (62).”
Xia, J., Tang, N., Wu, X., & Ren, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1033145 · Cited by 34
Du, H., Xiao, N., Zhang, S., Zhou, X., Zhang, Y., Lu, Z., Fu, Y., Huang, M., Xu, S., & Chen, Q. (2023) · iScience · doi:10.1016/j.isci.2023.107090 · Cited by 35
Shi, Y., Taherifard, E., Saeed, A., & Saeed, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060356 · Cited by 38
A nutrigeroscience approach: Dietary macronutrients and cellular senescence
Calubag, M. F., Robbins, P. D., & Lamming, D. W. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.025 · Cited by 35
Chen, P., Yang, C., Ren, K., Xu, M., Pan, C., Ye, X., & Li, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1504948 · Cited by 38
Therapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
The intestinal microbiome and surgical disease
Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 39
The CF gastrointestinal microbiome: Structure and clinical impact
Rogers, G. B., Narkewicz, M. R., & Hoffman, L. R. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23544 · Cited by 37
Wang, H., Shang, X., Wan, X., Xiang, X., Mao, Q., Deng, G., & Wu, Y. (2016) · Scientific Reports · doi:10.1038/srep38180 · Cited by 36
Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC
Liu, K., & McCaughan, G. W. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_2 · Cited by 36
Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease
Chashmniam, S., Ghafourpour, M., Farimani, A. R., Gholami, A., & Gh, B. F. N. M. (2019) · Hepatitis Monthly · doi:10.5812/hepatmon.92244 · Cited by 36
Dietary Recombinant Phycoerythrin Modulates the Gut Microbiota of H22 Tumor-Bearing Mice
Qi, H., Liu, Y., Qi, X., Liang, H. W., Chen, H., Jiang, P., & Wang, D. (2019) · Marine Drugs · doi:10.3390/md17120665 · Cited by 36
Microbiome and host crosstalk: A new paradigm to cancer therapy
Singh, A. K., Nayak, N., Rathi, P., Verma, D., Sharma, R., Chaudhary, A., Agarwal, A., Tripathi, Y. B., & Garg, N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.014 · Cited by 35
Emerging role of microbiota in immunomodulation and cancer immunotherapy
Singh, R. P., Bashir, H., & Kumar, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.008 · Cited by 35
Behary, J., Raposo, A. E., Amorim, N. M. L., Zheng, H., Gong, L., McGovern, E., Chen, J., Liu, K., Beretov, J., Theocharous, C., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02171-9 · Cited by 36
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
Rivera‐Andrade, A., Petrick, J. L., Álvarez, C. S., Graubard, B. I., Florio, A. A., Kroker-Lobos, M. F., Parisi, D., Freedman, N. D., Lazo, M., Güallar, E., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16948 · Cited by 35
Manilla, V., Tommaso, N. D., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Microorganisms · doi:10.3390/microorganisms11020267 · Cited by 32
Li, X., Gu, X., Li, L., Xiang, L., Jiang, Z., Zhang, Y., Li, S., Li, J., Li, J., & Yi, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1170748 · Cited by 47
Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma
Shen, S., Khatiwada, S., Behary, J., Kim, R., & Zekry, A. (2022) · Cancers · doi:10.3390/cancers14092099 · Cited by 34
Advances and challenges in the treatment of osteosarcoma
Wang, X., Zhu, K., Hu, J., & Zhang, C. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.07.001 · Cited by 38
Lao, Y., Li, Y., Zhang, P., Shao, Q., Lin, W., Qiu, B., Lv, Y., Tang, L., Su, S., Zhang, H., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.016 · Cited by 32
Save your gut save your age: The role of the microbiome in stem cell ageing
Tan, Y. J., Wei, Z., Chen, J., An, J., Li, M., Zhou, L., Men, Y., & Zhao, S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14373 · Cited by 34
Mouzaki, M., & Loomba, R. S. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819858470 · Cited by 33
The Microbiome and Its Implications in Cancer Immunotherapy
Choudhry, H. (2021) · Molecules · doi:10.3390/molecules26010206 · Cited by 31
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.